Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Comment
Devi Sridhar

Meningitis is back – and here is why

Students queue for antibiotics at the University of Kent in Canterbury on 17 March 2026.
Students queue for antibiotics at the University of Kent in Canterbury on 17 March 2026. Photograph: Gareth Fuller/PA

With the tragedy of two young people dying, and a further 13 confirmed cases, meningitis is back in the headlines in the UK, prompting public concern and worry about the risk. What’s happening and why?

Meningitis has been an ongoing public health concern for decades. Back in the 1990s, around 2,500 lab-confirmed cases of meningococcal disease were recorded annually, largely caused by meningococcal group C bacteria – the disease is caused by a range of bacterial strains, each of which require a different targeted vaccine to prepare the immune system. With the adoption of the MenC vaccine in 1999, cases of group C disease fell by around 96% to roughly 30-40 cases per year. Soon after, vaccination programmes were expanded to cover groups ACWY, which caused steep declines in all of those groups, because the vaccines reduce the transmission of infections.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.